Related references
Note: Only part of the references are listed.Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast
Min Hua et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution
D. Craig Allred et al.
CLINICAL CANCER RESEARCH (2008)
Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: Longitudinal results from a cohort study
Ann Partridge et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Ductal carcinoma in situ of the breast: 11 reasons to consider treatment with excision alone
Melvin J. Silverstein
WOMENS HEALTH (2008)
Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer
Rulla M. Tamimi et al.
BREAST CANCER RESEARCH (2008)
The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas
Jason I. Herschkowitz et al.
BREAST CANCER RESEARCH (2008)
Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and def ines basal-like breast tumors
Mona L. Gauthier et al.
CANCER CELL (2007)
Identification of a basal-like subtype of breast ductal carcinoma in situ
Chad A. Livasy et al.
HUMAN PATHOLOGY (2007)
Histoplathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast - Results from the Swedish randomised trial
A. Ringberg et al.
EUROPEAN JOURNAL OF CANCER (2007)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Ductal carcinoma in situ with basal-like phenotype:: a possible precursor to invasive basal-like breast cancer
BB Bryan et al.
MODERN PATHOLOGY (2006)
Trends in breast cancer by race and ethnicity: Update 2006
C Smigal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2006)
Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence
N Barnes et al.
BRITISH JOURNAL OF CANCER (2006)
The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS - A population-based analysis
JL Warren et al.
CANCER (2005)
Genes that mediate breast cancer metastasis to lung
AJ Minn et al.
NATURE (2005)
Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast
LJ Solin et al.
CANCER (2005)
Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast
NLP Barnes et al.
CLINICAL CANCER RESEARCH (2005)
p38 regulates cyclooxygenase-2 in human mammary epithelial cells and is activated in premalignant tissue
ML Gauthier et al.
CANCER RESEARCH (2005)
High nuclear grade and negative estrogen receptor are significant risk factors for recurrence in DCIS
S Roka et al.
EJSO (2004)
Histologically normal human mammary epithelia with silenced p16INK4a overexpress COX-2, promoting a premalignant program
YG Crawford et al.
CANCER CELL (2004)
The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast - A study of a large cohort of patients treated with surgery alone
DB Cornfield et al.
CANCER (2004)
Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy
K Kerlikowske et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast
E Provenzano et al.
EUROPEAN JOURNAL OF CANCER (2003)
Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics
A Ringberg et al.
EUROPEAN JOURNAL OF CANCER (2001)
Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation:: Long-term outcome and prognostic significance of patient age and margin status
LJ Solin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Predicting axillary nodal positivity in 2282 patients with breast carcinoma
MJ Silverstein et al.
WORLD JOURNAL OF SURGERY (2001)
Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breast
AG Douglas-Jones et al.
JOURNAL OF CLINICAL PATHOLOGY (2000)
Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program
VL Ernster et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Pathologists' agreement with experts and reproducibility of breast ductal carcinoma-in-situ classification schemes
WA Wells et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2000)
Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853
JP Julien et al.
LANCET (2000)
Share Paper
